Project List
List projects.
Fields
id (integer)
Primary key.
Expansions
To activate relation expansion add the desired fields as a comma separated
list to the expand query parameter like this:
?expand=<field>,<field>,<field>,...
The following relational fields can be expanded:
organizationcategorytypepartner_functionmanagercontactstatusgrantresearcheventstudylanguageprogramfunders
Filters
To filter for exact value matches:
?<fieldname>=<value>
Possible exact filters:
organizationcategorymanagercontactstatusgrantresearchstudylanguagefundersprogram
For advanced filtering use lookups:
?<fieldname>__<lookup>=<value>
All fields with advanced lookups can also be used for exact value matches as described above.
Possible advanced lookups:
begin_planned:gt,gte,lt,ltebegin_effective:gt,gte,lt,lteend_planned:gt,gte,lt,lteend_effective:gt,gte,lt,lte
GET /v1/research/project/?format=api&offset=1720&ordering=-end_effective
{ "count": 2265, "next": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=1740&ordering=-end_effective", "previous": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=1700&ordering=-end_effective", "results": [ { "id": 2980, "title": { "de": "Gewebedatenbank zur Erforschung der stadienabhängigen Herzinsuffizienz Graz", "en": "Tissue database Graz for the investigation of stage-dependent heart failure" }, "short": "GESHG", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2012-10-01T02:00:00+02:00", "begin_effective": "2012-10-01T02:00:00+02:00", "end_planned": "2014-09-30T02:00:00+02:00", "end_effective": "2013-09-30T02:00:00+02:00", "assignment": "2012-09-20T11:36:28+02:00", "program": null, "subprogram": null, "organization": 14083, "category": 10, "type": 10, "partner_function": 4, "manager": 59941, "contact": 59941, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 457 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2980-59941-10" ] }, { "id": 2886, "title": { "de": "Kardioposturale Interaktionen und Endothelfunktion in Abhängigkeit vom Menstruationszyklus", "en": "Cardiopostural interactions and endothelial function chagnes across the menstural cycle" }, "short": "KARPEM", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2012-05-20T02:00:00+02:00", "begin_effective": "2012-06-01T02:00:00+02:00", "end_planned": "2012-08-20T02:00:00+02:00", "end_effective": "2013-09-30T02:00:00+02:00", "assignment": "2012-06-14T13:45:08+02:00", "program": null, "subprogram": null, "organization": 14010, "category": 10, "type": 10, "partner_function": 1, "manager": 57932, "contact": 57932, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2886-57932-10" ] }, { "id": 2906, "title": { "de": "Der Einfluss der Proteinkinase D2 auf den Glukosemetabolismus von Glioblastomzellen.", "en": "Protein Kinase D2 and its influence on the glucose metabolism of glioblastoma cells." }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2012-03-01T01:00:00+01:00", "begin_effective": "2012-07-01T02:00:00+02:00", "end_planned": "2012-05-31T02:00:00+02:00", "end_effective": "2013-09-30T02:00:00+02:00", "assignment": "2012-06-28T10:34:12+02:00", "program": null, "subprogram": null, "organization": 14013, "category": 10, "type": 10, "partner_function": 4, "manager": 50990, "contact": 50990, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2906-50990-10" ] }, { "id": 2376, "title": { "de": "GATIB II - Subprojekt 4", "en": "GATIB II - Subproject 4" }, "short": "GATIB II - Subprojekt 4", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2010-10-01T02:00:00+02:00", "begin_effective": "2010-10-01T02:00:00+02:00", "end_planned": "2013-09-30T02:00:00+02:00", "end_effective": "2013-09-30T02:00:00+02:00", "assignment": "2011-01-10T14:46:48+01:00", "program": 73, "subprogram": null, "organization": 14026, "category": 10, "type": 10, "partner_function": 4, "manager": 51344, "contact": 51344, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 152 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2376-51344-10" ] }, { "id": 2546, "title": { "de": "MSc in Migrant Health: Adressing New Challenges in Europe", "en": "MSc in Migrant Health: Adressing New Challenges in Europe" }, "short": "MSC IN MIGRANT HEALTH", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-01-01T01:00:00+01:00", "begin_effective": "2010-10-01T02:00:00+02:00", "end_planned": "2013-12-31T01:00:00+01:00", "end_effective": "2013-09-30T02:00:00+02:00", "assignment": "2011-07-28T12:19:44+02:00", "program": null, "subprogram": "Erasmus", "organization": 29447, "category": 10, "type": 10, "partner_function": 2, "manager": 51521, "contact": 51521, "status": 2, "research": 5, "grant": 10, "event": null, "study": null, "language": null, "funders": [], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2546-51521-10" ] }, { "id": 2489, "title": { "de": "Etablierung eines künstlichen Blutgefäßmodells zur Entwicklung von Gefäßprothesen", "en": "Artifical blood vessel model for the development of vascular protheses" }, "short": "Artifical blood vessel model", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-10-04T02:00:00+02:00", "begin_effective": "2011-10-01T02:00:00+02:00", "end_planned": "2012-12-04T01:00:00+01:00", "end_effective": "2013-09-30T02:00:00+02:00", "assignment": "2011-05-30T18:05:42+02:00", "program": null, "subprogram": "Human Technology Interface", "organization": 14017, "category": 10, "type": 10, "partner_function": 4, "manager": 51718, "contact": 51718, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2489-76930-12", "2489-51718-10" ] }, { "id": 1878, "title": { "de": "Anandamide/LPI signaling & function in endothelial cells", "en": "Anandamide/LPI signaling & function in endothelial cells" }, "short": "Anandamide/LPI", "url": null, "abstract": { "de": "Anandamide (ANA), also known as N-arachidonoylethanolamine, is a prominent substance of endocannabinoids, and exhibits multiple physiological functions in the brain, the immune system and the cardiovasculature. Although ANA is well known to contribute to human behavior, like eating and sleeping, and pain relief, evidence accumulated that ANA is an important vascular mediator that is released during tissue stress. LPI (lysophosphatidylinositol is another putatively important lipid mediator in the vessel wall.\r\nThe overall aim of this project is to explore ANA/LPI as important vascular mediators, to characterize their respective signal transduction, their interrelation and consequences to endothelial cell functions. In the end, our proposal aims to provide the scientific basis of consideration of the ANA/LPI system as therapeutic target for vascular-related medicine.", "en": "Anandamide (ANA), also known as N-arachidonoylethanolamine, is a prominent substance of endocannabinoids, and exhibits multiple physiological functions in the brain, the immune system and the cardiovasculature. Although ANA is well known to contribute to human behavior, like eating and sleeping, and pain relief, evidence accumulated that ANA is an important vascular mediator that is released during tissue stress. LPI (lysophosphatidylinositol is another putatively important lipid mediator in the vessel wall.\r\nThe overall aim of this project is to explore ANA/LPI as important vascular mediators, to characterize their respective signal transduction, their interrelation and consequences to endothelial cell functions. In the end, our proposal aims to provide the scientific basis of consideration of the ANA/LPI system as therapeutic target for vascular-related medicine." }, "begin_planned": "2009-07-01T02:00:00+02:00", "begin_effective": "2009-10-01T02:00:00+02:00", "end_planned": "2012-06-30T02:00:00+02:00", "end_effective": "2013-09-30T02:00:00+02:00", "assignment": "2009-07-30T13:21:16+02:00", "program": 72, "subprogram": null, "organization": 14013, "category": 10, "type": 10, "partner_function": 4, "manager": 51860, "contact": 51860, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "P21857", "ethics_committee": null, "edudract_number": null, "persons": [ "1878-50810-11", "1878-51860-10" ] }, { "id": 1577, "title": { "de": "Identification of specific endothelial binding-sites for inflammatory carbamylated low-density lipoproteins", "en": "Identification of specific endothelial binding-sites for inflammatory carbamylated low-density lipoproteins" }, "short": "CARBAMYL_LDL_FWF08", "url": null, "abstract": { "de": "In renal disease, elevated levels of urea lead to an increased concentration of cyanate that reacts irreversible with amino groups of proteins through carbamylation reactions. High concentrations of carbamylated low-density-lipoproteins (cLDL) have recently been reported to accumulate in plasma of pateints with chronic renal failure, indicating that cLDL is by far the most abundant modified LDL found in human plasa. Of importance, carbamylated proteins may also be formed directly at sites of inflammation - even in the absence of renal disease- via the phagocyte derived inflammatory mediator myeloperoxidase (MPO). Active MPO is present in human atherosclerotic lesion material and has been shown to bind to low- and high-density lipoproteins. Thus, it can be assumed that MPO derived cyanate contributes to lipoprotein carbamylation at sites of inflammation. Recent clinical studies demonstrated that carbamylated proteins predict increased risk of coronary artery disease, future myocardial infarction, stroke and death.\r\n\r\nNo endothelial receptors of binding proteins that might trigger the potent pro-atherosclerotic effects of carbamylated LDL have yet been identified. Therefore, the aim of the proposed project is to identify endothelial receptors for carbamylated LDL and to systemically examine the impact of carbamylated LDL on the expression of inflammatory genes in human derived vascular endothelial cells.", "en": "In renal disease, elevated levels of urea lead to an increased concentration of cyanate that reacts irreversible with amino groups of proteins through carbamylation reactions. High concentrations of carbamylated low-density-lipoproteins (cLDL) have recently been reported to accumulate in plasma of pateints with chronic renal failure, indicating that cLDL is by far the most abundant modified LDL found in human plasa. Of importance, carbamylated proteins may also be formed directly at sites of inflammation - even in the absence of renal disease- via the phagocyte derived inflammatory mediator myeloperoxidase (MPO). Active MPO is present in human atherosclerotic lesion material and has been shown to bind to low- and high-density lipoproteins. Thus, it can be assumed that MPO derived cyanate contributes to lipoprotein carbamylation at sites of inflammation. Recent clinical studies demonstrated that carbamylated proteins predict increased risk of coronary artery disease, future myocardial infarction, stroke and death.\r\n\r\nNo endothelial receptors of binding proteins that might trigger the potent pro-atherosclerotic effects of carbamylated LDL have yet been identified. Therefore, the aim of the proposed project is to identify endothelial receptors for carbamylated LDL and to systemically examine the impact of carbamylated LDL on the expression of inflammatory genes in human derived vascular endothelial cells." }, "begin_planned": "2008-10-01T02:00:00+02:00", "begin_effective": "2008-10-01T02:00:00+02:00", "end_planned": "2011-09-30T02:00:00+02:00", "end_effective": "2013-09-30T02:00:00+02:00", "assignment": "2008-07-14T14:41:55+02:00", "program": 72, "subprogram": null, "organization": 14022, "category": 10, "type": 10, "partner_function": 4, "manager": 53252, "contact": 53252, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "P21004", "ethics_committee": null, "edudract_number": null, "persons": [ "1577-53252-10" ] }, { "id": 2904, "title": { "de": "Prognostische und therapeutische Relevanz von steatohepatitischen Veränderungen beim Hepatozellulären Karzinom", "en": "Prognostic and therapeutic relevance of steatohepatitic features in hepatocellular carinoma" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2012-08-01T02:00:00+02:00", "begin_effective": "2012-08-01T02:00:00+02:00", "end_planned": "2013-08-01T02:00:00+02:00", "end_effective": "2013-08-31T02:00:00+02:00", "assignment": "2012-06-27T13:08:00+02:00", "program": null, "subprogram": null, "organization": 14020, "category": 10, "type": 10, "partner_function": 4, "manager": 50871, "contact": 50871, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2904-50871-10" ] }, { "id": 3053, "title": { "de": "Genetische Charakterisierung einer steirischen Familie mit einem familiären kolorektalen Syndrom X", "en": "Genetic characterization of a Styrian family with colorectal cancer type X" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2012-11-01T01:00:00+01:00", "begin_effective": "2012-11-01T01:00:00+01:00", "end_planned": "2013-11-01T01:00:00+01:00", "end_effective": "2013-07-31T02:00:00+02:00", "assignment": "2012-11-27T13:32:52+01:00", "program": null, "subprogram": null, "organization": 14082, "category": 10, "type": 10, "partner_function": 4, "manager": 77615, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "3053-77615-10" ] }, { "id": 1777, "title": { "de": "The role of C/EBPa on the development of monocyte subsets", "en": "The role of C/EBPa on the development of monocyte subsets" }, "short": "C/EBPa", "url": null, "abstract": { "de": "The integrity of the hematopoietic system depends on a large number of blood cell lineages being continuously replenished from a rare population of pluripotent heatopoietic stem cells(HSC), representing a paradigm for how multilineage diversity can be achieved from a common stem cell through lineage commitment and subsequent differentiation.\r\nMonocytes are mononuclear cells and represent about 10% of leukocytes in human blood and 4% of leukocytes in mouse blood. The best known function of monocytes is their role as accessory cells, which link inflammation and the innate defense system against microorganisms to adaptive immune response.\r\nMany factors are involved in monocyte differentiation like PU.1, IRF8, KLF-4, MafB, c-maf and C/EBPalpha. C/EBPalpha (CCAAT/enhancer binding protein alpha) is a basic region-leucine zipper transcription factor and indispensable for formation of mature neutrophils and eosinophils. It is expressed at low levels in HSC, and is up-regulated to its highest levels in GMP(granulocyte/monocyte progenitors), whereas it is not expressed in precursors of lymphoid cells and is downregulated as CMP differentiate to MEP(megakaryocyte/erythrocyte progenitors). Mice-studies indicate that C/EBPalpha is essential for transition of CMP to GMP.\r\n\r\nWe hypothesize that C/EBPalpha positive and C/EBPalpha negative monocytes represent distinct subgroups of monocytes, which also differ in their function. In addition, we speculate that they are derived from different progenitors. To experimentally approach this hypothesis we want to use the C/EBPalphaCRE EYFP reporter mouse model.", "en": "The integrity of the hematopoietic system depends on a large number of blood cell lineages being continuously replenished from a rare population of pluripotent heatopoietic stem cells(HSC), representing a paradigm for how multilineage diversity can be achieved from a common stem cell through lineage commitment and subsequent differentiation.\r\nMonocytes are mononuclear cells and represent about 10% of leukocytes in human blood and 4% of leukocytes in mouse blood. The best known function of monocytes is their role as accessory cells, which link inflammation and the innate defense system against microorganisms to adaptive immune response.\r\nMany factors are involved in monocyte differentiation like PU.1, IRF8, KLF-4, MafB, c-maf and C/EBPalpha. C/EBPalpha (CCAAT/enhancer binding protein alpha) is a basic region-leucine zipper transcription factor and indispensable for formation of mature neutrophils and eosinophils. It is expressed at low levels in HSC, and is up-regulated to its highest levels in GMP(granulocyte/monocyte progenitors), whereas it is not expressed in precursors of lymphoid cells and is downregulated as CMP differentiate to MEP(megakaryocyte/erythrocyte progenitors). Mice-studies indicate that C/EBPalpha is essential for transition of CMP to GMP.\r\n\r\nWe hypothesize that C/EBPalpha positive and C/EBPalpha negative monocytes represent distinct subgroups of monocytes, which also differ in their function. In addition, we speculate that they are derived from different progenitors. To experimentally approach this hypothesis we want to use the C/EBPalphaCRE EYFP reporter mouse model." }, "begin_planned": "2009-05-01T02:00:00+02:00", "begin_effective": "2009-08-01T02:00:00+02:00", "end_planned": "2010-04-30T02:00:00+02:00", "end_effective": "2013-07-31T02:00:00+02:00", "assignment": "2009-04-07T10:52:48+02:00", "program": null, "subprogram": null, "organization": 14082, "category": 10, "type": 10, "partner_function": 4, "manager": 51911, "contact": 51911, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 423 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "1777-58889-12", "1777-51911-10" ] }, { "id": 2431, "title": { "de": "Genetic predisposition to therapy-related myeloid neoplasms: involvement of the Fanconi anemia/BRCA pathway?", "en": "Genetic predisposition to therapy-related myeloid neoplasms: involvement of the Fanconi anemia/BRCA pathway?" }, "short": "FANCONI ANEMIA BRCA", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2010-01-01T01:00:00+01:00", "begin_effective": "2010-01-01T01:00:00+01:00", "end_planned": "2011-12-31T01:00:00+01:00", "end_effective": "2013-07-31T02:00:00+02:00", "assignment": "2011-02-28T11:28:49+01:00", "program": 79, "subprogram": null, "organization": 14082, "category": 10, "type": 10, "partner_function": 4, "manager": 51857, "contact": 51857, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 12 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2431-77371-12", "2431-77615-12", "2431-51857-10", "2431-50116-12" ] }, { "id": 2119, "title": { "de": "Alzheimer drugs incorporated in nanoparticles for specific transport over the blood brain barrier (NanoBrain)", "en": "Alzheimer drugs incorporated in nanoparticles for specific transport over the blood brain barrier (NanoBrain)" }, "short": "NanoBrain", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2010-01-01T01:00:00+01:00", "begin_effective": "2010-10-01T02:00:00+02:00", "end_planned": "2013-12-31T01:00:00+01:00", "end_effective": "2013-07-31T02:00:00+02:00", "assignment": "2010-02-12T14:34:51+01:00", "program": 64, "subprogram": "ERA-Net", "organization": 14051, "category": 10, "type": 10, "partner_function": 2, "manager": null, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "I453", "ethics_committee": null, "edudract_number": null, "persons": [] }, { "id": 2526, "title": { "de": "Rezeptoren und Metabolite von Prostaglandinen im Morbus Crohn und der ulzerösen Kolitis", "en": "DP receptors and their prostaglandin metabolite ligands: a good or bad match for human IBD?" }, "short": "DP receptors in IBD", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-08-01T02:00:00+02:00", "begin_effective": "2011-08-01T02:00:00+02:00", "end_planned": "2013-07-31T02:00:00+02:00", "end_effective": "2013-07-31T02:00:00+02:00", "assignment": "2011-07-12T16:34:21+02:00", "program": 79, "subprogram": null, "organization": 14022, "category": 10, "type": 10, "partner_function": 4, "manager": 56687, "contact": 56687, "status": 2, "research": 3, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 12 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2526-56687-10" ] }, { "id": 3018, "title": { "de": "Automatisierte Erkennung eines Herzgeräusches (Systolikums) mittels Phonokardiographie", "en": "Automated analysis of cardial murmurs with phonocardiography" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2012-08-01T02:00:00+02:00", "begin_effective": "2012-08-01T02:00:00+02:00", "end_planned": "2013-07-31T02:00:00+02:00", "end_effective": "2013-07-31T02:00:00+02:00", "assignment": "2012-10-31T11:54:12+01:00", "program": null, "subprogram": null, "organization": 14094, "category": 10, "type": 10, "partner_function": 4, "manager": 50907, "contact": 50907, "status": 2, "research": 4, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "3018-50907-10" ] }, { "id": 3285, "title": { "de": "Endoskopische, bildverarbeitungsgestützte Diagnostik frühmagnialer Veräderungen bei Barretts-Ösophagus", "en": "Endoskopische, bildverarbeitungsgestützte Diagnostik frühmagnialer Veräderungen bei Barretts-Ösophagus" }, "short": "EBIDAVROS", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-08-01T02:00:00+02:00", "begin_effective": "2011-08-01T02:00:00+02:00", "end_planned": "2012-08-31T02:00:00+02:00", "end_effective": "2013-07-30T02:00:00+02:00", "assignment": "2013-05-23T11:43:59+02:00", "program": null, "subprogram": "HTI", "organization": 14081, "category": 10, "type": 10, "partner_function": 2, "manager": 51539, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "3285-51539-10" ] }, { "id": 2548, "title": { "de": "Ko-Kultursystem für die frühe Plazentation mit unterschiedlichen Sauerstoffkonzentrationen", "en": "Co-Culture System for early placentation with different oxygen-concentrations" }, "short": "CO-CULTURE SYSTEM EARLY PLACENTATION", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2011-03-01T01:00:00+01:00", "begin_effective": "2011-08-01T02:00:00+02:00", "end_planned": "2012-02-28T01:00:00+01:00", "end_effective": "2013-07-30T02:00:00+02:00", "assignment": "2011-07-28T15:36:26+02:00", "program": null, "subprogram": null, "organization": 14017, "category": 10, "type": 10, "partner_function": 4, "manager": 58943, "contact": 58943, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2548-58943-10" ] }, { "id": 3014, "title": { "de": "Der Schmerz und seine Begleitaspekte - Evaluation des postoperative Schmerzerlebens bei Kindern und Jugendlichen", "en": "Evaluation of the postoperative painexperience in children and adolescent" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2012-07-01T02:00:00+02:00", "begin_effective": "2012-10-01T02:00:00+02:00", "end_planned": "2012-10-31T01:00:00+01:00", "end_effective": "2013-07-30T02:00:00+02:00", "assignment": "2012-10-25T10:02:24+02:00", "program": null, "subprogram": null, "organization": 14026, "category": 10, "type": 10, "partner_function": 4, "manager": 67207, "contact": 67207, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "3014-67207-10" ] }, { "id": 2860, "title": { "de": "Arterial Stiffness, Stress Coping and Health Locus of Control", "en": "Arterial Stiffness, Stress Coping and Health Locus of Control" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2012-05-01T02:00:00+02:00", "begin_effective": "2012-05-01T02:00:00+02:00", "end_planned": "2013-07-30T02:00:00+02:00", "end_effective": "2013-07-30T02:00:00+02:00", "assignment": "2012-05-16T10:57:28+02:00", "program": null, "subprogram": null, "organization": 29447, "category": 10, "type": 10, "partner_function": 4, "manager": 60388, "contact": 60388, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "2860-60388-10" ] }, { "id": 3016, "title": { "de": "Reduzierter Opioidverbrauch durch Physostigmin als Dauertropf zur postoperativen PCA - PHANOS (PHysostigmine-enHAnced Opioid analgeSia) Folgestudie", "en": "PHANOS - PHysostigmine-enHAnced Opioid analgeSia" }, "short": "PHANOS", "url": null, "abstract": { "de": "Zahlreiche Studien haben gezeigt, dass cholinerge Mechanismen eine zentrale Rolle im antinozizeptiven System spielen, indem sie synergistisch mit Morphin wirken und den postoperativen Opioidverbrauch reduzieren. Darüber hinaus hat das Anti-Cholinesterase-Medikament Physostigmin, das die synaptische Acetylcholin-Konzentration erhöht, entzündungshemmende Wirkungen. In dieser randomisierten, placebokontrollierten Studie mit 110 Patienten, die sich einer Nephrektomie unterzogen, untersuchten wir die Auswirkungen einer intraoperativen Physostigmin-Infusion von 0,5 mg h-1 i.v. über 24 Stunden auf den Opioidverbrauch, die Hyperalgesie, die Schmerzwerte und die Zufriedenheit mit der Schmerzkontrolle. \r\n\r\nÜbersetzt mit www.DeepL.com/Translator (kostenlose Version)", "en": "Several studies have shown that cholinergic mechanisms play a pivotal role in the anti-nociceptive system by acting synergistically with morphine and reducing postoperative opioid consumption. In addition, the anti-cholinesterase drug physostigmine that increases synaptic acetylcholine concentrations has anti-inflammatory effects. In this randomised placebo-controlled trial including 110 patients undergoing nephrectomy, we evaluated the effects of intraoperative physostigmine 0.5 mg h-1 i.v. for 24 h on opioid consumption, hyperalgesia, pain scores, and satisfaction with pain control. " }, "begin_planned": "2012-07-01T02:00:00+02:00", "begin_effective": "2012-11-01T01:00:00+01:00", "end_planned": "2014-12-31T01:00:00+01:00", "end_effective": "2013-07-30T02:00:00+02:00", "assignment": "2012-10-25T16:06:20+02:00", "program": null, "subprogram": "Land Steiermark unter 5.000,-", "organization": 14069, "category": 10, "type": 10, "partner_function": 4, "manager": 58422, "contact": null, "status": 2, "research": 4, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "3016-58422-10", "3016-51915-12" ] } ] }